PNC Financial Services Group’s Organogenesis Holdings ORGO Stock Holding History

PNC Financial Services Group’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107	Buy	+44	New	+$108	﹤0.01%	5140
2026 Q1	–	Sell	-5	Closed	-$26	–	5274
2025 Q4	$26	Hold	5	–	–	﹤0.01%	5124
2025 Q3	$21	Hold	5	–	–	﹤0.01%	5059
2025 Q2	$18	Buy	+5	New	+$19	﹤0.01%	4888
2024 Q1	–	Sell	-12	Closed	-$49	–	4780
2023 Q4	$49	Buy	+12	New	+$34	﹤0.01%	4567
2023 Q2	–	Sell	-284	Closed	-$605	–	4806
2023 Q1	$605	Sell	284 -2,495	-90%	-$6.16K	﹤0.01%	4505
2022 Q4	$7.47K	Sell	2,779 -3,979	-59%	-$11.6K	﹤0.01%	3870
2022 Q3	$22K	Buy	6,758 +2,180	+48%	+$9.85K	﹤0.01%	3401
2022 Q2	$23K	Buy	4,578 +1,211	+36%	+$7.45K	﹤0.01%	3434
2022 Q1	$26K	Sell	3,367 -1,213	-26%	-$9.39K	﹤0.01%	3450
2021 Q4	$42K	Buy	4,580 +2,258	+97%	+$24K	﹤0.01%	3207
2021 Q3	$33K	Buy	2,322 +327	+16%	+$5.08K	﹤0.01%	3295
2021 Q2	$34K	Buy	+1,995	New	+$37.2K	﹤0.01%	3256

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PNC Financial Services Group's ORGO Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 44 shares worth $107. The stake represents ﹤0.01% of the portfolio and ranks #5140 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in ORGO as recently as Q4 2025.

PNC Financial Services Group first reported a position in ORGO in Q2 2021 and has held it in 13 quarters since. The position peaked at $42K in Q4 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

PNC Financial Services Group held 44 shares of Organogenesis Holdings worth $107 as of Q2 2026.
Organogenesis Holdings was a new PNC Financial Services Group position in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5140 holding.
PNC Financial Services Group first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 13 quarters since.
PNC Financial Services Group's Organogenesis Holdings position peaked at $42K in Q4 2021.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.